A.O.U Careggi

Running trials

• Recruiting

  A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

  NCT07595653· Source

• Recruiting

  Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer

  NCT07389265· Phase 3· Source

• Active, not recruiting

  Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

  NCT06183489· Phase 2· Source

• Recruiting

  Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

  NCT06375941· Source

• Recruiting

  European Myeloma Network (EMN) Sample Project

  NCT06237803· Source

• Recruiting

  Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD

  NCT05924100· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Multiple myeloma1 recruiting
• Myasthenia gravis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

  NCT04471428· Phase 3· Source

• Completed

  A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista

  NCT04487067· Phase 3· Source